openPR Logo
Press release

Uveitis Market: Trends, Growth, and Industry Analysis | Forecast 2024-2031

02-20-2024 02:31 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Uveitis Market - DataM Intelligence

Uveitis Market - DataM Intelligence

Uveitis Industry Size
The Global Uveitis Market size was valued at US$ 456 million in 2022 and is estimated to reach US$ 837 million by 2031, growing at a CAGR of 4.8% during the forecast period (2024-2031).

Uveitis is a condition characterized by inflammation of the uvea, which is the middle layer of tissue in the eyewall. This inflammation can affect various parts of the eye, including the iris, ciliary body, and choroid. It predominantly affects individuals between the ages of 20 and 50 years. While uveitis can range from mild to severe, it has the potential to cause serious complications, including vision loss, if left untreated. Therefore, prompt diagnosis and appropriate management are essential to minimize the risk of vision impairment associated with uveitis.

For More Insights Request Free Sample - https://www.datamintelligence.com/download-sample/uveitis-market

Uveitis Industry Trends

The market for uveitis medications is expected to witness growth driven by an increasing product pipeline from pharmaceutical companies and advancements in technology leading to the development of new drugs.

Key drivers for the uveitis market include advancements in technology, the growing geriatric population, increased research and development investments, and a rising prevalence of ophthalmic disorders such as uveitis, glaucoma, cataracts, and age-related macular degeneration (AMD). Additionally, improvements in medical infrastructure, especially in emerging markets, contribute to market expansion.

Uveitis medications, including eye drops, injections, pills, or implants, are widely used for treatment purposes. The adoption of these medications is increasing, supported by rising government initiatives and funding. These funds facilitate the development of uveitis medication products to address the growing prevalence of ophthalmic disorders worldwide. Furthermore, the availability of technologically advanced products by key players is expected to drive market growth.

Various novel product launches, research studies, and awareness initiatives contribute to the market's growth. For instance, in November 2022, Alimera Sciences, Inc., announced the reimbursement approval for ILUVIEN (fluocinolone acetonide intravitreal implant) for non-infectious uveitis in Europe. This sustained-release intravitreal implant represents a significant advancement in uveitis treatment, underscoring ongoing efforts to improve outcomes for patients with this condition.

View Full Report: https://www.datamintelligence.com/research-report/uveitis-market

Uveitis Industry Segmentation

By Uveitis Type
Anterior Uveitis
Intermediate Uveitis
Posterior Uveitis
Pan Uveitis

By Medications
Corticosteroids
Anti-Rheumatic Drugs
Cycloplegic-Mydriatic Drugs
Immunomodulatory Therapy
Biological Therapy
Anti-Viral Drugs
Others

By Medication Form
Eye Drops
Pills
Injections
Implants

By End-User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Industry Key Players

Major players are Novartis Inc., AbbVie, Johnson & Johnson Services, Inc., Amgen, Alimera Sciences, Bausch & Lomb Incorporated., Kiora Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., EyePoint Pharmaceuticals, Inc and Clearside Biomedical.


Trending Reports

Ocular Trauma Devices Market - https://www.datamintelligence.com/research-report/ocular-trauma-devices-market

Corneal Topographers Market - https://www.datamintelligence.com/research-report/corneal-topographers-market

Artificial Iris Market - https://www.datamintelligence.com/research-report/artificial-iris-market

Vitreoretinal Surgery Devices Market - https://www.datamintelligence.com/research-report/vitreoretinal-surgery-devices-market

DataM Intelligence 4market Research LLP
Ground floor, DSL Abacus IT Park,
Industrial Development Area, Uppal,
Hyderabad, Telangana 500039
Website: https://www.datamintelligence.com/

DataM Intelligence 4Market Research is a market intelligence platform that gives access to syndicated, customized reports and consulting to its clients in one place. As a firm with rich experience in research and consulting across multiple domains, we are a one-stop solution that will cater to the needs of clients in key business areas. DataM Intelligence has an online platform whose coverage includes industries such as chemicals and materials, agriculture, health care services, animal feed, and food & beverages, among others. Our platform has Insights on markets that uncover the latest market research data that are distinct from the competition. With coverage across 10 major industries in the marketplace research, DataM Intelligence benefits thousands of companies by helping them take their innovations early to the market by providing a complete view of the market with statistical forecasts. Our strategy-centric framework and value-added services will let individuals and corporates ease access and custom personalization to research and markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Uveitis Market: Trends, Growth, and Industry Analysis | Forecast 2024-2031 here

News-ID: 3391869 • Views:

More Releases from DataM Intelligence 4Market Research

IV Bags Market Set for Strong Growth as Hospital Admissions and Infusion Therapies 2025-2032 | Top Companies - Baxter, Pfizer, Inc., Fresenius Kabi AG, JW Life Science.
IV Bags Market Set for Strong Growth as Hospital Admissions and Infusion Therapi …
Market Overview: The IV Bags Market is expected to grow at a CAGR of 5% during the forecasting period 2024-2031. The IV Bags Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it
Feed Electrolytes Market is expected to reach US$ 28.3 billion by 2032 | Major players - Royal DSM, Tanke Biosciences Corp, BASF SE, DuPont.
Feed Electrolytes Market is expected to reach US$ 28.3 billion by 2032 | Major p …
Market Size and Growth: The Global Feed Electrolytes Market size reached US$ 3.64 billion in 2024 and is expected to reach US$ 28.3 billion by 2032, growing with a CAGR of 5.7% during the forecast period 2024-2032. The Feed Electrolytes Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed
Used Cooking Oil Market Set to Explode as Governments Push Circular Biofuel Solutions 2025-2032 | Major players - Georgia-Pacific Chemicals LLC, Kraton Corporation, Eagle Imports.
Used Cooking Oil Market Set to Explode as Governments Push Circular Biofuel Solu …
Market Overview: The Used Cooking Oil Market is expected to reach at a CAGR of 7.4% during the forecast period 2024-2031. The Used Cooking Oil Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research
Anionic Surfactant Market is expected to reach US$ 24.3 billion by 2032 | Major players - SNF Floerger, Kemira Oyj, BASF SE, Ecolab Inc.
Anionic Surfactant Market is expected to reach US$ 24.3 billion by 2032 | Major …
Market Size and Growth: The Global Anionic Surfactant Market size reached US$ 14.7 billion in 2024 and is expected to reach US$ 24.3 billion by 2032, growing with a CAGR of 6.4% during the forecast period 2025-2032. The Anionic Surfactant Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed

All 5 Releases


More Releases for Uveitis

Uveitis Market : An Overview Report
Introduction: Uveitis is an inflammatory condition affecting the uvea, the middle layer of the eye. It can lead to vision impairment or even blindness if left untreated. Uveitis is categorized into different types, including anterior, intermediate, posterior, and panuveitis, depending on the part of the eye affected. The condition can be caused by infections, autoimmune diseases, or trauma. With increasing cases of autoimmune disorders and infectious diseases, the prevalence of uveitis
Uveitis Treatment Market Size, Share | Trend 2030
Exclusive Report by Ameco Research: Uveitis Treatment Market Size Projected to Reach USD 2 Billion by 2030, Growing at 6% CAGR Ameco Research is proud to announce the launch of its latest market research report, Uveitis Treatment Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research
Uveitis - Drug Pipeline Landscape, 2022
New York, Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of
Uveitis - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on Uveitis - Drug Pipeline Landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. Uveitis is an inflammation of the eye which damages the part of the eye called the uvea and affects other parts of the eyes which causes pain to the eyes. There are 4 types of uveitis based
Japan Industry Statistics of Uveitis Treatment
Global Uveitis Treatment Market: Overview Uveitis, an autoimmune eye disease, is considered rare for just around 38 in 100,000 people are afflicted by it. Because of this, it is often overlooked. Patients afflicted by uveitis are often referred to an expert after much delay on account of less awareness about the eye malady. This delays timely diagnosis and results in irreversible damage to various ocular structures. Read Report Overview: https://www.transparencymarketresearch.com/uveitis-treatment-market.html As per Cochrane,
Uveitis Treatment Market Analysis of Top industry Scenario
Global Uveitis Treatment Market report it provides a vital recent industry data which covers in general market situation along with future scenario for industry around the Globe. It also consists of major data along with forecasts of a global market along with clear presentation of diagrams (charts and tables). According to a new report published by Allied Market Research, titled, "Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy &